Patient disposition.
MM, HGG, glioma, GVHD
MULTIPLE MYELOMA, BILIARY TRACT CANCER, HAIRY CELL LEUKEMIA, GRAFT VERSUS HOST DISEASE, GVHD, GERM CELL TUMOR, GLIOMA, GIST, ANAPLASTIC THYROID CANCER, ADENOCARCINOMA OF SMALL INTESTINE
*Reasons for screen failures were not collected ASI, adenocarcinoma of small intestine; ATC, anaplastic thyroid cancer; BTC, biliary tract cancer; DP, declined to participate; EC, expansion cohort; GCT, germ cell tumor; GIST, gastrointestinal stromal tumor; G, grade; GVHD, graft versus host disease; HCL, hairy cell leukemia; HGG, high (WHO G3/G4) grade glioma; ID, investigator discretion; LF, lost to follow-up; LGG, low (WHO G1/G2) grade glioma; MM, multiple myeloma; NIC, not meeting inclusion criteria; OR, other reasons; PAC, primary analysis cohort; ST, study terminated by sponsor; WC, withdrew consent; WHO, World Health Organization.
